| [1] |
Zijlstra JM, Lindauer-van der Werf G, Hoekstra OS, et al.
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review[J]. HaematologicaHaematologica, 2006, 91(4): 522-529.
|
| [2] |
Terasawa T, Nihashi T, Hotta T, et al.
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review[J]. J Nucl MedJ Nucl Med, 2008, 49(1): 13-21.
doi: 10.2967/jnumed.107.039867
|
| [3] |
Juweid ME, Wiseman GA, Vose JM, et al.
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography[J]. J Clin OncolJ Clin Oncol, 2005, 23(21): 4652-4661.
doi: 10.1200/JCO.2005.01.891
|
| [4] |
Picardi M, De Renzo A, Pane F, et al.
Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans[J]. Leuk LymphomaLeuk Lymphoma, 2007, 48(9): 1721-1727.
doi: 10.1080/10428190701559140
|
| [5] |
Mikhaeel NG, Hutchings M, Fields PA, et al.
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma[J]. Ann OncolAnn Oncol, 2005, 16(9): 1514-1523.
doi: 10.1093/annonc/mdi272
|
| [6] |
Spaepen K, Stroobants S, Dupont P, et al.
Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma[J]. Ann OncolAnn Oncol, 2002, 13(9): 1356-1363.
doi: 10.1093/annonc/mdf256
|
| [7] |
Hutchings M, Loft A, Hansen M, et al.
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma[J]. BloodBlood, 2006, 107(1): 52-59.
doi: 10.1182/blood-2005-06-2252
|
| [8] |
Mikhaeel NG.
Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?[J]. Leuk LymphomaLeuk Lymphoma, 2009, 50(12): 1931-1936.
doi: 10.3109/10428190903275610
|
| [9] |
Terasawa T, Dahabreh IJ, Nihashi T.
Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis[J]. OncologistOncologist, 2010, 15(7): 750-759.
doi: 10.1634/theoncologist.2010-0054
|
| [10] |
Lin C, Itti E, Haioun C, et al.
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis[J]. J Nucl MedJ Nucl Med, 2007, 48(10): 1626-1632.
doi: 10.2967/jnumed.107.042093
|
| [11] |
Torizuka T, Nakamura F, Kanno T, et al.
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2004, 31(1): 22-28.
doi: 10.1007/s00259-003-1333-8
|
| [12] |
Itti E, Juweid ME, Haioun C, et al.
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background[J]. J Nucl MedJ Nucl Med, 2010, 51(12): 1857-1862.
doi: 10.2967/jnumed.110.080556
|
| [13] |
Crocchiolo R, Canevari C, Assanelli A, et al.
Pre-transplant 18FDGPET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation[J]. Leuk LymphomaLeuk Lymphoma, 2008, 49(4): 727-733.
doi: 10.1080/10428190701885545
|